NCT02152384View on ClinicalTrials.gov

A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin Peglispro

Administered SC

DRUG

Insulin Lispro

Administered SC

DRUG

Insulin Glargine

Administered SC

Trial Locations (1)

41460

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02152384 - A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements | Biotech Hunter | Biotech Hunter